Healthcare Sales & Marketing Network News: BioTherapeutics

Searching News Database: BioTherapeutics

HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Aug 2021
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2021
Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 1 Jun 2021
Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 29 Apr 2021
Capsida Biotherapeutics Debuts with $140 Million of Capital
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Feb 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 11 Feb 2021
Protalix BioTherapeutics Enters into an Exclusive Partnership with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Respiratory Diseases Via Inhaled Delivery
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 7 Jan 2021
Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Nov 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 29 Sep 2020
Prometheus Biosciences Appoints Olivier Laurent, Ph.D. as Chief Technology Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 19 Aug 2020
Apexigen Appoints Jakob Dupont to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Aug 2020
Sobi appoints Dr Ravi Rao as new Head of Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jul 2020
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 May 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals

HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Apr 2020
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Apr 2020
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Mar 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Dec 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Nov 2019
Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 18 Nov 2019
Protalix BioTherapeutics and Chiesi Farmaceutici Announce Successful pre-BLA Meeting with FDA for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Nov 2019
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2019
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Aug 2019
Zoll Medical Completes Acquisition of Cardiac Science
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 30 Jul 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX(R) Platform Technology
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 May 2019
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Apr 2019
510(k) Market Clearance for FluChip-8G Influenza A+B Assay
Diagnostics FDA

HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 23 Apr 2019
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2019
Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2019
NW Bio Hires David Innes As Vice President, Investor Relations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Feb 2019
Viriom Announces New CEO Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jan 2019
Israeli Start-up Laminate, Developer of a Vascular Support Solution for Dialysis Patients, Has Completed a Capital Raising Round of $12 Million
Devices Venture Capital

HSMN NewsFeed - 9 Jan 2019
NapaJen Pharma Closes $12.4 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Aug 2018
CardioVascular BioTherapeutics, Inc. Appoints Dr. David M. Ornitz and Dr. Arnold I. Chin to its Scientific and Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2018
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
Biopharmaceuticals Product Launch

HSMN NewsFeed - 1 Aug 2018
IGM Biosciences Appoints Daniel S. Chen, M.D., Ph.D., as Chief Medical Officer; Names William Strohl, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2018
RubrYc Therapeutics Completes $10M Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Feb 2018
GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Dec 2017
Protalix BioTherapeutics� PRX-102 Granted Orphan Drug Designation by the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Dec 2017
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 27 Nov 2017
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2017
HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema
Biopharmaceuticals Product Launch

HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Regenerative Medicine Neurology

HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 May 2017
New MRI Data from Asterias' Ongoing SCiStar Clinical Study Indicates AST-OPC1 Cells Prevent Formation of Damaging Lesion Cavities in Patients Suffering Severe Spinal Cord Injury
Regenerative Medicine Neurosurgery

HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology

HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Mar 2017
New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2017
aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2016
aTyr Pharma Receives FDA Fast Track Designation for Resolaris(TM) to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2016
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Sep 2016
Zosano Appoints Georgia Erbez as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jul 2016
Pernix Therapeutics Announces Reorganization of Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2016
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2015
Bellerophon Therapeutics Announces Leadership Team Changes
Devices Drug Delivery Personnel

HSMN NewsFeed - 15 Sep 2015
Jounce Therapeutics Appoints Kim Drapkin, CPA as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 3 Aug 2015
CytomX Announces Management Team Promotions
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Aug 2015
Soligenix Enters into a $10 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jun 2015
Vaxil's Lead Product ImMucin has Been Granted an Orphan Drug Designation by the FDA for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel

HSMN NewsFeed - 21 May 2015
Jose-Carlos Guti�rrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 15 Apr 2015
Tenax Therapeutics Provides Clinical and Corporate Update
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Mar 2015
Atara Biotherapeutics, Inc. Appoints Eric Dobmeier, Chief Operating Officer of Seattle Genetics, Inc., to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Dec 2014
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 25 Nov 2014
Eleven Biotherapeutics Announces Additional Financing of $20 Million
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Nov 2014
Intellia Therapeutics Announces $15 Million in Funding to Develop Therapeutic Products Utilizing CRISPR-Cas9 Gene Editing Technology
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS

HSMN NewsFeed - 24 Oct 2014
QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jul 2014
MYOS Corporation Appoints World Renowned Scientific Visionary and Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2014
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2014
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2014
ARIAD Announces Three Key Appointments to Its Global Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2014
Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2014
Coherus BioSciences Secures $55 million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 May 2014
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2014
Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2014
Atara Biotherapeutics Strengthens Board and Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Biopharmaceuticals Devices Personnel

HSMN NewsFeed - 24 Mar 2014
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2014
Ambrx Appoints Barry Greene to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 31 Dec 2013
George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2013
Oxygen Biotherapeutics Closes the Acquisition of Phyxius Pharma Assets Related to Levosimendan; John Kelley Appointed CEO of Oxygen Biotherapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Nov 2013
ImmunGene Raises $9 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Sep 2013
Cubist Pharmaceuticals Appoints Kenneth Martin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2013
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Devices

HSMN NewsFeed - 16 May 2013
NW Bio Initiates Phase III DCVax(R)-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 May 2013
Third Rock Ventures Expands and Strengthens Team
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 3 May 2013
Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
Regenerative Medicine Neurology Licensing

HSMN NewsFeed - 7 Feb 2013
Fully Automatic AED Plus from ZOLL Granted 510(k) Clearance by U.S. Food and Drug Administration
Devices Cardiology FDA

HSMN NewsFeed - 6 Feb 2013
ZOLL Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market Intravascular Temperature Management Technology
Devices Regulatory Distribution

HSMN NewsFeed - 31 Jan 2013
Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema (HAE) and Other Angioedema Indications in Latin America
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Jan 2013
Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Dec 2012
Aequus BioPharma Appoints Ronald J. Berenson, M.D. President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2012
Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer for ELELYSO(TM) (taliglucerase alfa)
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2012
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
Biopharmaceuticals Wound Care Orthopaedic Acquisitions

HSMN NewsFeed - 24 Oct 2012
ZOLL Establishes Japanese Subsidiary, Asahi Kasei ZOLL Medical
Devices

HSMN NewsFeed - 16 Oct 2012
ZOLL Medical and GS GmbH (corpuls) Form Licensing Agreement to Incorporate ZOLL�s Real CPR Help in corpuls Defibrillators
Devices Cardiology Licensing

HSMN NewsFeed - 11 Oct 2012
Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2012
Study Supports Efficacy, Safety of Hizentra(R) in Japanese Patients with Primary Immunodeficiency Disease
Biopharmaceuticals

HSMN NewsFeed - 20 Aug 2012
Dyax Corp. Creates COO Position and Expands Executive Roles
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2012
Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 May 2012
Northwest Bio Provides Update On DCVax(R)-L Brain Cancer Trial
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO(TM) (taliglucerase alfa) For The Treatment Of Gaucher Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 3 Jan 2012
CSL Behring Receives FDA Approval of Expanded Label on Berinert(R) for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 2 Dec 2011
Pfizer Completes Acquisition of Excaliard
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Nov 2011
Pfizer to Acquire Excaliard Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2011
Healthpoint Biotherapeutics Acquires Regranex(R) Gel
Biopharmaceuticals Wound Care Acquisitions

HSMN NewsFeed - 12 May 2011
SpringLeaf Therapeutics Raises $15M Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Apr 2011
PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2011
FDA Issues Complete Response Letter for Taliglucerase Alfa New Drug Application
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2011
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jan 2011
CSL Behring Receives National Marketing Authorization of Berinert(R) in Israel
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Jan 2011
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Jan 2011
Dyax and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Jan 2011
FDA Extends Marketing Exclusivity for INOMAX(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2010
Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Nov 2010
Sutro Biopharma Secures $36.5 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Oct 2010
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2010
Minnow Medical Names Raymond W. Cohen as Chief Executive Officer
Devices Interventional Personnel

HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2010
OrbiMed Expands Private Equity Team
Venture Capital Personnel

HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel

HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Sep 2010
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Sep 2010
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Sep 2010
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2010
Talecris Biotherapeutics and Grifols Receive FTC Request for Additional Information Regarding Proposed Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals

HSMN NewsFeed - 15 Jul 2010
Ikaria(R) Names Chief Science Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 29 Jun 2010
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2010
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2010
Ikaria(R) Names New Head of Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Apr 2010
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Mar 2010
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
Biopharmaceuticals Dermatology

HSMN NewsFeed - 1 Mar 2010
Baxter and ApaTech Announce Definitive Agreement
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 1 Mar 2010
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
Regenerative Medicine Personnel

HSMN NewsFeed - 17 Feb 2010
Eleven Biotherapeutics Completes $35 Million Series A Funding to Advance Pipeline of Innovative Protein-Based Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Feb 2010
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2010
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2009
Dean Mitchell Appointed to Talecris Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2009
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Dec 2009
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 9 Dec 2009
Oxford BioTherapeutics Appoints Michael Moore as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2009
FDA Grants First Approval for a Product Derived from Pichia pastoris
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA

HSMN NewsFeed - 1 Dec 2009
Dyax Announces FDA Approval of KALBITOR(R) (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Oct 2009
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2009
Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
Biopharmaceuticals Regenerative Medicine Oncology

HSMN NewsFeed - 19 Oct 2009
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2009
CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Sep 2009
GENova Biotherapeutics prepares a 510(k) submission to the FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Sep 2009
FDA Grants Protalix Orphan Drug Designation for prGCD
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Sep 2009
GENova names Dr. John Savin as Vice President
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Aug 2009
Protalix Receives FDA Fast Track Designation for prGCD
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Aug 2009
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Aug 2009
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jul 2009
Limerick BioPharma Raises $15 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Jun 2009
Calcionics Appoints Daniel O. Wilds Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2009
Talecris Biotherapeutics Receives Orphan Drug Designation for Plasmin (Human) to Treat Acute Peripheral Arterial Occlusion
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Apr 2009
RXi Pharmaceuticals Appoints Richard Chin, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2009
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 24 Mar 2009
Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2009
Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
Devices FDA

HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Devices Biopharmaceuticals

HSMN NewsFeed - 11 Mar 2009
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Feb 2009
Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care

HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 4 Feb 2009
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Feb 2009
Regenerative Medicine Company Garnet Biotherapeutics Raises $10.4 Million
Regenerative Medicine Dermatology Venture Capital

HSMN NewsFeed - 29 Jan 2009
Safeguard Scientifics Joins $10.4 Million Financing of Garnet Biotherapeutics
Regenerative Medicine Venture Capital

HSMN NewsFeed - 27 Jan 2009
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
Devices Wound Care FDA

HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2009
CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 1 Oct 2008
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2008
Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Devices Personnel

HSMN NewsFeed - 29 Sep 2008
Tekmira Pharmaceuticals Expands Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2008
Oxygen Biotherapeutics, Inc. Announces License Agreement for Its Glucose Biosensor Technology
Devices Monitoring Licensing

HSMN NewsFeed - 15 Sep 2008
FDA Grants Approval to Talecris Biotherapeutics for Gamunex(R) as a Treatment for Neurological Disorder CIDP in the United States
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Sep 2008
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
Devices Wound Care Personnel

HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2008
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Aug 2008
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
Biopharmaceuticals Wound Care

HSMN NewsFeed - 11 Aug 2008
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Biopharmaceuticals Distribution Personnel

HSMN NewsFeed - 7 Aug 2008
Dyax Corp. Announces the Appointment of George Migausky as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2008
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jul 2008
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Form of Alpha1-Antitrypsin (AAT) From the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jul 2008
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Jul 2008
Ikaria(R) Strengthens Research & Development Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Jun 2008
Lentigen Appoints Jim Meade as Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Biopharmaceuticals Wound Care

HSMN NewsFeed - 15 May 2008
Haemacure appoints Reinaldo M. Diaz to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 24 Apr 2008
Genentech Announces Decision in Contract Dispute
Biopharmaceuticals Litigation

HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Biopharmaceuticals

HSMN NewsFeed - 24 Apr 2008
Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications
Biopharmaceuticals

HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Biopharmaceuticals

HSMN NewsFeed - 30 Mar 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Business Combination to Create Global Leader in RNAi Delivery and Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 14 Mar 2008
Genentech Provides Business Update at Annual Investment Community Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2008
CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2008
Pfizer Presents New Opportunities for Global Growth
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2008
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Feb 2008
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
Biopharmaceuticals

HSMN NewsFeed - 25 Feb 2008
Last Patient Enrolled In ATryn(R) Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2008
FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2008
Positive Results from Phase III Trial of Gamunex(R) in Patients with CIDP
Biopharmaceuticals

HSMN NewsFeed - 25 Jan 2008
Genentech and Biogen Idec Announce Positive Results from a Phase III Trial of Rituxan in Patients with Rheumatoid Arthritis Who Inadequately Responded to Methotrexate
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2008
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jan 2008
Alder Biopharmaceuticals Inc. Completes $40M Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2008
Dr. Laurence Lasky, Ph.D. Joins U.S. Venture Partners
Venture Capital Personnel

HSMN NewsFeed - 19 Dec 2007
CSL Behring Expands Into Middle East Market with Haemate(R) P
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2007
Pfizer to Acquire CovX to Extend Biotherapeutics Investment
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Dec 2007
Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
Biopharmaceuticals Devices Surgery FDA

HSMN NewsFeed - 10 Dec 2007
GTC Obtains FDA Orphan Drug Designation For ATryn(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Dec 2007
Mary Ann Gray Elected to GTC Biotherapeutics Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2007
Genentech Provides Update from Avastin FDA Advisory Meeting
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Dec 2007
Protalix BioTherapeutics Announces Resignation of Board Members
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2007
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2007
Dyax Announces Plans for Retirement of Steve Galliker as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2007
Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2007
MedImmune Announces Seven Key Promotions and New Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2007
Biotech Veteran Joins AerovectRx as CEO
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 31 Oct 2007
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Oct 2007
Xencor Expands Series E Financing to $60 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Oct 2007
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2007
Xcellerex Raises $31 Million in Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2007
Alethia Biotherapeutics Inc. Announces in-Licensing of Family of Monoclonal Antibodies to Treat Metastatic Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 2 Oct 2007
CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
Biopharmaceuticals Wound Care

HSMN NewsFeed - 1 Oct 2007
Ikaria Names Executive Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
Study Demonstrates Aerosolized Prolastin(R) Using Unique Nebulizer Results in High Levels of Drug Deposited in Peripheral Regions of Lungs
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Aug 2007
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Biopharmaceuticals

HSMN NewsFeed - 24 Aug 2007
Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jul 2007
CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
Biopharmaceuticals Devices Drug Delivery Cardiology FDA

HSMN NewsFeed - 9 Jul 2007
World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Jul 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval to Use Cryoprecipitate from Talecris Biotherapeutics, Inc. in Its Manufacturing Process
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jun 2007
Cyclacel Pharmaceuticals Announces Appointment of Distinguished Pharma Executive as Senior Vice President, Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2007
Lewis T. 'Rusty' Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2007
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in First-Line Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 May 2007
Medarex and Organon Announce Biotherapeutics Development Agreement
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 May 2007
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
Biopharmaceuticals Surgery Cardiology

HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2007
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2007
Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2007
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Apr 2007
Humate-P(R) Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Apr 2007
Dyax Announces the Appointment of Gustav Christensen as Executive Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2007
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Apr 2007
Northwest Biotherapeutics Files for Authorization for Use of DCVax(R)-Brain for Commercialization in Switzerland
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Apr 2007
Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
Biopharmacetuicals

HSMN NewsFeed - 12 Apr 2007
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2007
Phase Bioscience Strengthens Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2007
Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs
Biopharmaceuticals

HSMN NewsFeed - 13 Mar 2007
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
Biopharmaceuticals

HSMN NewsFeed - 13 Mar 2007
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Mar 2007
Northwest Biotherapeutics, Inc. Appoints Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Mar 2007
Orthodontix Announces Name Change to Protalix BioTherapeutics, Inc.
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
Study Finds C1-Inhibitor Concentrate Is Safe and Effective in Treating Skin Swelling in Patients With Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2007
Analysis of International Phase III Study of Avastin(R) Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Feb 2007
Genentech Provides Update on Cabilly Patent Reexamination
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2007
Nabi Biopharmaceuticals Announces Resignation of Thomas McLain as CEO and Appointment of Leslie Hudson as Interim CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2007
Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 1 Feb 2007
CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 1 Feb 2007
Xencor Appoints Jade R. Brown as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2007
Pfizer Announces Priorities to Drive Improved Performance, Position Company for Future Success and Enhance Total Shareholder Return
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
Genentech Announces Senior Vice President and Vice President Promotions in Commercial, Legal and Product Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2007
U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
Regenerative Medicine Cardiology

HSMN NewsFeed - 8 Jan 2007
Juvaris Announces First Round Closing of Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jan 2007
CSL Behring Reports Progress on Global Implementation of Name Change
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 3 Jan 2007
ATryn(R) Market Authorization Transferred To LEO Pharma A/S
Biopharmaceuticals

HSMN NewsFeed - 2 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
Biopharmaceuticals Group Purchasing

HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Dec 2006
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 15 Dec 2006
Receptor BioLogix Names Four New Senior Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2006
New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Dec 2006
Interim Analysis of Phase III Trial Shows Avastin Plus Interferon Therapy Improved Progression-Free Survival in Patients With Previously Untreated Advanced Renal Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Dec 2006
Talecris Continues Global Expansion into Europe
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2006
Northwest Biotherapeutics Receives Institutional Review Board Approval to Accrue Patients in Phase II Brain Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Nov 2006
Positive Final Results from EDEMA2 Trial with DX-88 for the Treatment of Hereditary Angioedema Presented at ACAAI Meeting
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Yaupon Therapeutics Closes $4 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Nov 2006
Genentech Announces Agreement to Acquire Tanox for $20 Per Share
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Nov 2006
Genentech Announces Manufacturing Agreements with Lonza
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2006
CardioVascular BioTherapeutics Initiates Study on the Treatment of Peripheral Artery Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Oct 2006
CardioVascular BioTherapeutics Appoints Mike Norris Vice President of Business Development
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 17 Oct 2006
CardioVascular BioTherapeutics Elects Dr. Thomas Stegmann Co-President
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 11 Oct 2006
FDA Approves Avastin(R) in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Oct 2006
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2006
New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 Oct 2006
Genentech and CGI Pharmaceuticals Enter Into Exclusive Global Strategic Alliance for Potential Products in Multiple Oncology and Autoimmune Indications
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Oct 2006
GTC Biotherapeutics and LFB Biotechnologies Enter Strategic Collaboration for Recombinant Plasma Proteins and Monoclonal Antibodies
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Sep 2006
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing

HSMN NewsFeed - 21 Sep 2006
Shareholders of Inex Pharmaceuticals Approve Spin Out of Tekmira Pharmaceuticals Corporation
Biopharmaceuticals

HSMN NewsFeed - 8 Sep 2006
Protiva Files Suit Against Inex in California Superior Court
Biopharmaceuticals Litigation

HSMN NewsFeed - 5 Sep 2006
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Biopharmaceuticals

HSMN NewsFeed - 31 Aug 2006
Dyax Announces Update Regarding Regulatory Pathway for DX-88 (ecallantide) in Hereditary Angioedema
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Aug 2006
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 28 Aug 2006
Genentech and Biogen Idec Announce Positive Results From a Phase II Trial of Rituxan in Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Aug 2006
CardioVascular BioTherapeutics Co-Founder Presents Seminar on Potential New Heart Disease Treatment
Biopharmaceuticals Regenerative Medicine Cardiology

HSMN NewsFeed - 2 Aug 2006
European Commission Approves ATryn(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 30 Jun 2006
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jun 2006
Analysis of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage in Rheumatoid Arthritis Patients Who Respond Inadequately to TNF Antagonist Therapies
Biopharmaceuticals

HSMN NewsFeed - 20 Jun 2006
FDA Approves Avastin(R) in Combination With Chemotherapy for Second-Line Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Jun 2006
Results From a Randomized Phase II Trial Suggested the Combinations of Avastin(R) Plus Tarceva(R) and Avastin Plus Chemotherapy Improved Progression- Free Survival in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2006
Preliminary Results from a Phase IIIb Study Showed Patients With Wet AMD Treated With Lucentis Quarterly Experienced a 16-Letter Benefit Over the Control Group at One Year
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 2 Jun 2006
ATryn(R) Receives CHMP Recommendation to Grant Market Authorization
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2006
Genentech Submits Supplemental Biologics License Application for Avastin With Chemotherapy in First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 May 2006
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2006
Northwest Biotherapeutics Updates Brain Cancer Clinical Data
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 May 2006
CVBT Achieves Safety Milestone in Clinical Heart Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 May 2006
Dyax Provides Update on Regulatory Pathway for DX-88
Biopharmaceuticals FDA

HSMN NewsFeed - 11 May 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2006
INEX Files Counterclaim Against Protiva Biotherapeutics
Biopharmaceuticals Litigation

HSMN NewsFeed - 26 Apr 2006
CardioVascular BioTherapeutics, Inc. Announces Initiation of Clinical Studies to Treat Patients with Chronic Back Pain
Biopharmaceuticals

HSMN NewsFeed - 11 Apr 2006
Genentech Submits Supplemental Biologics License Application for Avastin(R) With Chemotherapy in First-Line, Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Apr 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2006
Genentech and Biogen Idec Submit Supplemental Biologics License Application for First-Line Use of Rituxan(R) in Low-Grade or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Mar 2006
Genentech Provides Updates at Annual Investment Meeting
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Phase III Clinical Study Shows Vivaglobin(R), a New Subcutaneous Immunoglobulin, Is Safe and Effective In Treating Patients With Primary Immunodeficiency
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Study Shows Individual Replacement Therapy With C1-Inhibitor Concentrate Reduces Life-Threatening Hereditary Angioedema Attacks Compared With Current Treatment of Choice
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Study Finds Treatment with C1-Inhibitor Concentrate Relieves Abdominal Pain in Hereditary Angioedema Patients
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Positive Topline Results from Phase II Trial (EDEMA2) with DX-88 for the Treatment of Hereditary Angioedema Presented at AAAAI Meeting
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2006
FDA Approves Rituxan(R) - The First Targeted B-Cell Therapy for Treatment of Moderate-to-Severe Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2006
Genentech Granted Six-Month Priority Review for Lucentis for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 24 Feb 2006
CVBT Comments that Imaging Modalities Being Developed by Philips Medical Systems have Direct Application to the Diagnosis and Treatment of Diseases CVBT is Targeting with Cardio Vascu-Grow(TM)
Devices Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Feb 2006
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
Biopharmaceuticals Group Purchasing

HSMN NewsFeed - 23 Feb 2006
CVBT Discusses Advances in Drug Development Program for New Stroke Treatments
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 22 Feb 2006
Brain Cancer Patients Living Longer and Doing Better After Personalized Vaccine Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Feb 2006
Genentech Submits Supplemental Biologics License Application for Adjuvant Herceptin(R) in Early-Stage HER2-Positive Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2006
American Pharmaceutical Partners and American BioScience Announce Senior Management Team of Abraxis BioScience
Biopharmaceuticals Personnel Mergers & Acquisitions

HSMN NewsFeed - 13 Feb 2006
Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2006
Dr. Thomas Stegmann, Cardiovascular Surgeon and Pioneer in Field of Angiogenesis, Commits to CVBT on a Full-Time Basis
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 26 Jan 2006
Amgen and Genentech Sign License Agreements For Antibody Patents
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Jan 2006
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
Biopharmaceuticals Interventional Cardiology Personnel

HSMN NewsFeed - 14 Jan 2006
Preliminary Phase III Data from Head-To-Head Study of Lucentis Shows Lucentis Improved Vision Compared to Visudyne in Patients with Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 9 Jan 2006
Genentech Announces Vice President Appointments in Commercial Operations, Corporate Information Technology, Product Development and Product Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2006
ZLB Behring Announces FDA Approval of Vivaglobin(R) - The First Subcutaneous Immunoglobulin Replacement Therapy Approved in the U.S.
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jan 2006
PharmAthene and Medarex Receive FDA Fast Track Designation for Valortim(TM) for Treatment of Anthrax Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2006
Genentech Announces Executive Promotions
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 227

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 227 additional stories matching:
BioTherapeutics
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.